Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis

Chen,Yong; Wang,Lijuan; Xu,Hexiang; Liu,Xingxiang; Zhao,Yingren

doi:10.3892/or.2013.2652

Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis

Authors:
- Yong Chen
- Lijuan Wang
- Hexiang Xu
- Xingxiang Liu
- Yingren Zhao
View Affiliations

Affiliations: Institute of Liver Diseases, Huai'an Fourth People's Hospital, Huai'an, Jiangsu 223002, P.R. China, Department of Infectious Diseases, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: August 2, 2013 https://doi.org/10.3892/or.2013.2652
Pages: 1906-1912

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC), the most common type of liver cancer, is the third primary cause of cancer-related mortality worldwide. The molecular mechanisms underlying the initiation and formation of HCC remain obscure. In the present study, we performed exome sequencing using tumor and normal tissues from 3 hepatitis B virus (HBV)-positive BCLC stage A HCC patients. Bioinformatic analysis was performed to find candidate protein-altering somatic mutations. Eighty damaging mutations were validated and 59 genes were reported to be mutated in HBV-related HCCs for the first time here. Further analysis using whole genome sequencing (WGS) data of 88 HBV-related HCC patients from the European Genome-phenome Archive database showed that mutations in 33 of the 59 genes were also detected in other samples. Variants of two newly found genes, ZNF717 and PARP4, were detected in more than 10% of the WGS samples. Several other genes, such as FLNA and CNTN2, are also noteworthy. Thus, the exome sequencing analysis of three BCLC stage A patients provides new insights into the molecular events governing the early steps of HBV-induced HCC tumorigenesis.

View Figures

View References

1	El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
3	Perz JF, Armstrong GL, Farrington LA, Hutin YJ and Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
4	Schütte K, Bornschein J and Malfertheiner P: Hepatocellular carcinoma - epidemiological trends and risk factors. Dig Dis. 27:80–92. 2009.PubMed/NCBI
5	Stratton MR: Exploring the genomes of cancer cells: progress and promise. Science. 331:1553–1558. 2011. View Article : Google Scholar : PubMed/NCBI
6	Stratton MR, Campbell PJ and Futreal PA: The cancer genome. Nature. 458:719–724. 2009. View Article : Google Scholar
7	Meyerson M, Gabriel S and Getz G: Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 11:685–696. 2010. View Article : Google Scholar : PubMed/NCBI
8	Sung WK, Zheng H, Li S, et al: Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 44:765–769. 2012. View Article : Google Scholar : PubMed/NCBI
9	Li M, Zhao H, Zhang X, et al: Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 43:828–829. 2011. View Article : Google Scholar : PubMed/NCBI
10	Tao Y, Ruan J, Yeh SH, et al: Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci USA. 108:12042–12047. 2011. View Article : Google Scholar : PubMed/NCBI
11	Totoki Y, Tatsuno K, Yamamoto S, et al: High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet. 43:464–469. 2011. View Article : Google Scholar : PubMed/NCBI
12	Li H and Durbin R: Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
13	Li H, Handsaker B, Wysoker A, et al: The sequence alignment/map format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
14	Koboldt DC, Zhang Q, Larson DE, et al: VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22:568–576. 2012. View Article : Google Scholar : PubMed/NCBI
15	Choi Y, Sims GE, Murphy S, Miller JR and Chan AP: Predicting the functional effect of amino acid substitutions and indels. PLoS One. 7:e466882012. View Article : Google Scholar : PubMed/NCBI
16	Ng PC and Henikoff S: SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812–3814. 2003. View Article : Google Scholar : PubMed/NCBI
17	Hussain SP, Schwank J, Staib F, Wang XW and Harris CC: TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 26:2166–2176. 2007. View Article : Google Scholar : PubMed/NCBI
18	Imbeaud S, Ladeiro Y and Zucman-Rossi J: Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin Liver Dis. 30:75–86. 2010. View Article : Google Scholar : PubMed/NCBI
19	Staib F, Hussain SP, Hofseth LJ, Wang XW and Harris CC: TP53 and liver carcinogenesis. Hum Mutat. 21:201–216. 2003. View Article : Google Scholar
20	Kew MC: Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 23:405–409. 2003. View Article : Google Scholar : PubMed/NCBI
21	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar
22	Scorsone KA, Zhou YZ, Butel JS and Slagle BL: p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res. 52:1635–1638. 1992.PubMed/NCBI
23	Bressac B, Kew M, Wands J and Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350:429–431. 1991. View Article : Google Scholar : PubMed/NCBI
24	Gouas DA, Shi H, Hautefeuille AH, et al: Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein. Carcinogenesis. 31:1475–1482. 2010.
25	Ladomery M and Dellaire G: Multifunctional zinc finger proteins in development and disease. Ann Hum Genet. 66:331–342. 2002. View Article : Google Scholar : PubMed/NCBI
26	Papavassiliou AG: Transcription factors: structure, function, and implication in malignant growth. Anticancer Res. 15:891–894. 1995.PubMed/NCBI
27	Hans MA, Müller M, Meyer-Ficca M, Bürkle A and Küpper JH: Overexpression of dominant negative PARP interferes with tumor formation of HeLa cells in nude mice: evidence for increased tumor cell apoptosis in vivo. Oncogene. 18:7010–7015. 1999. View Article : Google Scholar : PubMed/NCBI
28	Ai J, Huang H, Lv X, et al: FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem. 27:207–216. 2011. View Article : Google Scholar : PubMed/NCBI
29	Scheel C, Onder T, Karnoub A and Weinberg RA: Adaptation versus selection: the origins of metastatic behavior. Cancer Res. 67:11476–11480. 2007. View Article : Google Scholar : PubMed/NCBI